These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9200559)

  • 21. Inhibitory effects of desvenlafaxine on gastric slow waves, antral contractions, and gastric accommodation mediated via the sympathetic mechanism in dogs.
    Dai F; Lei Y; Chen JD
    Am J Physiol Gastrointest Liver Physiol; 2011 Oct; 301(4):G707-12. PubMed ID: 21757637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nesfatin-1 suppresses gastric contractions and inhibits interdigestive migrating contractions in conscious dogs.
    Watanabe A; Mochiki E; Kimura A; Kogure N; Yanai M; Ogawa A; Toyomasu Y; Ogata K; Ohno T; Suzuki H; Kuwano H
    Dig Dis Sci; 2015 Jun; 60(6):1595-602. PubMed ID: 25563722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans.
    Coleman NS; Marciani L; Blackshaw E; Wright J; Parker M; Yano T; Yamazaki S; Chan PQ; Wilde K; Gowland PA; Perkins AC; Spiller RC
    Aliment Pharmacol Ther; 2003 Nov; 18(10):1039-48. PubMed ID: 14616171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
    Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
    Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
    Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
    Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    de Ridder WJ; Schuurkes JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain.
    Kiso T; Ito H; Miyata K; Kamato T; Naitoh Y; Iwaoka K; Yamaguchi T
    Eur J Pharmacol; 2001 Nov; 431(1):35-41. PubMed ID: 11716840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ghrelin does not stimulate gastrointestinal motility and gastric emptying: an experimental study of conscious dogs.
    Ohno T; Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H
    Neurogastroenterol Motil; 2006 Feb; 18(2):129-35. PubMed ID: 16420291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a domain affecting agonist potency of meta-chlorophenylbiguanide in 5-HT3 receptors.
    Mochizuki S; Miyake A; Furuichi K
    Eur J Pharmacol; 1999 Mar; 369(1):125-32. PubMed ID: 10204690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
    Bartrup JT; Newberry NR
    J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.
    Inatomi N; Satoh H; Maki Y; Hashimoto N; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1989 Nov; 251(2):707-12. PubMed ID: 2810120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of orally vs. parenterally administrated trimebutine on gastrointestinal and colonic motility in dogs.
    Buéno L; Hondé C; Pascaud X; Junien JL
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):90B-93B. PubMed ID: 3609630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central effect of mu-opioid agonists on antral motility in conscious rats.
    Tsuchida D; Fukuda H; Koda K; Miyazaki M; Pappas TN; Takahashi T
    Brain Res; 2004 Oct; 1024(1-2):244-50. PubMed ID: 15451387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro.
    Buchheit KH; Buhl T
    Eur J Pharmacol; 1994 Sep; 262(1-2):91-7. PubMed ID: 7813582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of alpha 2-adrenergic receptor antagonist (midaglizole) on gastrointestinal motility in conscious dogs.
    Fujii K; Okajima M; Kawahori K; Murakami Y; Shimatani T
    Nihon Heikatsukin Gakkai Zasshi; 1989 Aug; 25(4):125-35. PubMed ID: 2576085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The stimulatory effect of dorsal vagal complex injection of pentagastrin on gastric motility in rats].
    Zhang R; Zhou L; Zhang BZ
    Sheng Li Xue Bao; 1993 Jun; 45(3):279-85. PubMed ID: 8235728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5-HT3 receptor agonists on voluntary ethanol intake in rats maintained on a limited access procedure.
    Dyr W; Kostowski W
    Alcohol Alcohol; 1997; 32(4):455-62. PubMed ID: 9269853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.